cis-p-Methoxycinnamoylagmatine (6)
(68.7 mg, 0.25 mmol) was added. After 3 hours, the reaction
mixture was evaporated, and the residue was purified with silica
gel column chromatography and preparative TLC (CHCl3–
MeOH–H2O = 24 : 8 : 1) to give 23 (22.6 mg, 27%).
To a solution of Agmatin sulfate (26.8 mg, 0.12 mmol) in H2O
(0.8 mL) was added saturated NaHCO3 aq. in order to adjust
the pH to 8. To this solution was added compound 18 (36.1 mg,
0.13 mmol) in acetone (1 mL) at 0 ЊC. After stirring for 3 days,
the reaction mixture was evaporated to remove acetone,
extracted with EtOAc, and the resulting aqueous layer was
evaporated to dryness. The residue was purified with HPLC
using a Cosmosil 5C18AR column (1% AcOH–30% MeOH
aq.) to give 6 (31.0 mg, 81%).
23: 1H-NMR (270 MHz, CD3OD, 18 ЊC): 7.45 (2H, d, J = 8.6
Hz), 6.73 (2H, d, J = 8.6 Hz), 6.69 (1H, d, J = 12.5 Hz), 5.89
(1H, d, J = 12.5 Hz), 4.40 (1H, m), 3.53–3.44 (4H, m), 3.39–3.34
(2H, m), 3.19 (4H, t, J = 5.6 Hz), 1.87–1.79 (1H, m), 1.71–1.52
(3H, m), 1.43 (9H, s) ppm; 13C-NMR (67.5 MHz, CD3OD, 19
ЊC): 181.7, 172.4, 169.8, 167.8, 159.2, 139.4, 132.5, 127.8, 120.6,
115.8, 82.2, 70.9, 70.2, 54.2, 42.0, 41.3, 40.4, 30.2, 28.8, 26.4
ppm; HR FAB MS (positive): [M ϩ H]ϩ Found m/z 507.2932,
C24H39O6N6 requires m/z 507.2931; IR (film) ν: 3273, 1655,
1514, 1252, 1173, 843 cmϪ1; [α]2D0 ϩ31.7 (c 0.5, MeOH).
6:1H-NMR (270 MHz, CD3OD, 20 ЊC): 7.49 (2H, d, J = 8.9
Hz), 6.86 (2H, d, J = 8.9 Hz), 6.66 (1H, d, J = 12.5 Hz), 5.90
(1H, d, J = 12.5 Hz), 3.78 (3H, s), 3.24 (2H, br s), 3.15 (2H, br
s), 1.57 (4H, br s) ppm; 13C-NMR (100 MHz, CD3OD, 20 ЊC):
175.5, 161.4, 158.6, 138.0, 132.2, 129.2, 122.3, 114.5, 55.7, 42.0,
39.7, 27.4, 27.2 ppm; HR FAB MS (positive): [M ϩ H]ϩFound
m/z 291.1823, C15H23O2N4 requires m/z 291.1821; IR (film)
N-{2-[(Fluorescein-4-isothiocyanato)amino]ethoxyethyl} Nꢀ-cis-
p-coumaroyl-D-arginine amide (1)
ν: 3163, 1643, 1512, 1255, 1176, 1093, 613 cmϪ1
.
Compound 23 (22.6 mg, 44.7 µmol) was dissolved in THF–H2O
(1 : 1) (0.6 mL) and TFA (1.5 mL) was added to this solution at
0 ЊC. After stirring for 2 hours, this solution was evaporated to
dryness to give a TFA salt of the resulting amine. The TFA salt
of the resulting amine (10.7 mg) was dissolved in methanol
(1 mL). To this solution, triethylamine (4.8 µL, 34.5 µmol) and
then fluorescein isothiocyanate (FITC) (isomer I, 6.6 mg, 17.0
µmol) were added at 0 ЊC. After stirring overnight at rt, the
reaction mixture was evaporated to dryness and the residue was
purified with preparative TLC (CHCl3–MeOH–H2O = 24 : 8 : 1)
to give 1 (21.0 mg, quant.).
N-(2-(tert-Butoxycarbonylamino)ethoxyethyl) Nꢀ-benzyloxy-
carbonyl-D-arginine amide (21)
Compound 19 (60.7 mg, 0.18 mmol, Fluka Co., Ltd.) was
dissolved in pyridine (1.3 mL), and to this solution was added
20 (27.0 mg, 0.13 mmol) followed by benzotriazole-1-yloxy-
tris(dimethylamino)phosphonium hexafluorophosphate (BOP)
(83.2 mg, 0.19 mmol) at 0 ЊC under an argon atmosphere. After
stirring for 15 hours, the reaction mixture was evaporated with
the addition of toluene to remove pyridine. The resulting resi-
due was purified with silica gel column chromatography and
preparative TLC (CHCl3–MeOH–AcOH = 10 : 2 : 1) to give 21
(54.2 mg, 85%).
1:1H-NMR (270 MHz, CD3OD, 18 ЊC): 8.03 (1H, d, J = 2.0
Hz), 7.66 (1H, br s), 7.38 (2H, d, J = 8.6 Hz), 7.20 (1H, d, J = 8.4
Hz), 7.13 (2H, d, J = 8.6 Hz), 6.70–6.58 (7H, m), 5.89 (1H, d,
J = 12.7), 4.30 (1H, m,), 3.94–3.37 (8H, m), 3.01 (2H, t, J = 7.0
Hz), 1.86–1.41 (4H, m) ppm; 13C-NMR (100 MHz, DMSO-d6,
18 ЊC): 180.2, 171.8, 169.6, 166.1, 165.5, 159.1, 158.2, 156.9,
155.2, 140.2, 137.7, 132.3, 130.0, 129.3, 127.8, 126.1, 125.2,
120.8, 120.2, 118.4, 115.8, 114.8, 111.0, 102.6, 69.0, 68.2, 52.3,
45.7, 43.9, 29.1, 25.0, 11.5 ppm; HR FAB MS (positive): [M ϩ
H]ϩ Found m/z 796.2778, C40H42O9N7S requires m/z 796.2765;
IR (film) ν: 3273, 1589, 1466, 1387, 1265, 1209, 1111 cmϪ1; [α]2D0
ϩ40.2 (c 1.0, DMSO).
21: 1H-NMR (270 MHz, CD3OD, 17 ЊC): 7.37–7.29 (5H, m),
5.11 (1H, d, J = 12.8 Hz), 5.07 (1H, d, J = 12.8 Hz), 4.10 (1H,
m), 3.49 (2H, t, J = 5.2 Hz), 3.45 (2H, t, J = 5.2 Hz), 3.36 (2H,
m), 3.20–3.16 (4H, m), 1.84–1.58 (4H, m), 1.42 (9H, s) ppm;
13C-NMR (67.5 MHz, CD3OD, 19 ЊC): 174.3, 158.3, 158.2,
137.9, 129.3, 128.9, 128.7, 80.1, 70.8, 70.2, 67.7, 56.0, 41.9, 41.3,
40.3, 30.4, 28.8, 26.3 ppm.; [M ϩ H]ϩ Found m/z 495.2912,
C23H39O6N6 requires m/z 495.2931; IR (film) ν: 3411, 1668,
1523, 1252, 1169, 845 cmϪ1; [α]2D0 Ϫ5.7 (c 0.5, MeOH).
N-{[2-(7-Amino-4-methylcoumarin-3-acetyl)amino]ethoxyethyl}
Nꢀ-cis-p-coumaroyl-D-arginine amide (24)
N-(2-(tert-Butoxycarbonylamino)ethoxyethyl) D-arginine amide
Compound 23 (31.1 mg, 61 µmol) was dissolved in THF–H2O
(1 : 1) (0.6 mL) and TFA (1.0 mL) was added to this solution
at 0 ЊC. After stirring for one hour, the reaction mixture
was evaporated to give a TFA salt of the resulting amine. The
TFA salt of the resulting amine was dissolved in DMF (0.5 mL)
and triethylamine (17.7 µL, 127.8 µmol) and then 7-amino-
4-methylcoumarin-3-acetic acid–NHS (AMCA–NHS) (8.4 mg,
25.5 µmol) in DMF (0.5 mL) was added to this solution
at 0 ЊC. After stirred overnight, the reaction mixture was
adjusted to pH 5 with acetic acid and evaporated to dryness.
The residue was then purified by HPLC using a Cosmosil
5C18AR column (1% AcOH–30% MeOH aq.) to give 24 (14.8
mg, 79%).
(22)
Compound 21 (146.6 mg, 0.27 mmol) was dissolved in
methanol (3 mL) and 10% Pd–C powder was added to this
solution. This solution was stirred for one hour under a
hydrogen atmosphere, filtered with Celite, and evaporated to
dryness to give 22 (100.8 mg, 91%).
22: 1H-NMR (270 MHz, CD3OD, 25 ЊC): 3.61 (1H, t, J = 6.3
Hz), 3.54 (2H, t, J = 4.9 Hz), 3.47 (2H, t, J = 5.6 Hz), 3.42 (2H,
m), 3.21 (4H, t, J = 5.9 Hz), 1.94 (3H, s), 1.81–1.72 (2H, m),
1.67–1.62 (2H, m), 1.43 (9H, s) ppm; 13C-NMR (67.5 MHz,
CD3OD, 19 ЊC): 181.8, 170.2, 158.8, 157.3, 81.7, 70.0, 69.2,
53.7, 41.2, 40.5, 39.9, 28.9, 28.5, 24.5, 24.1 ppm; HR FAB MS
(positive): [M ϩ H]ϩ Found 361.2550 m/z, C15H33O4N6 requires
361.2563 m/z; IR (film) ν: 3263, 1676, 1547, 1406, 1173, 1124
cmϪ1; [α]2D0 Ϫ4.4 (c 1.0, MeOH)
24:1H-NMR (400 MHz, CD3OD, 25 ЊC): 7.49 (1H, d, J = 9
Hz), 7.42 (2H, d, J = 9 Hz), 6.69 (2H, d, J = 9 Hz), 6.67 (1H, dd,
J = 2, 8 Hz), 6.64 (1H, d, J = 12 Hz), 6.51 (1H, d, J = 2 Hz), 5.86
(1H, d, J = 13 Hz), 4.42 (1H, dd, J = 6, 7 Hz), 3.54 (2H, s), 3.51
(5H, m), 3.37 (3H, m), 3.16 (2H, t, J = 7 Hz), 2.35 (3H, s), 1.82
(1H, m), 1.72–1.51 (3H, m) ppm; 13C-NMR (100 MHz,
CD3OD, 18 ЊC): 175.2, 173.9, 173.3, 170.0, 164.9, 159.4, 158.6,
155.9, 153.6, 153.0, 139.5, 132.6, 127.9, 127.5, 120.7, 116.0,
114.6, 113.5, 112.0, 100.7, 70.3, 70.2, 54.3, 42.0, 40.6, 40.5, 35.2,
30.2, 26.3, 20.7, 15.4 ppm; HR FAB MS (positive): [M ϩ H]ϩ
Found 622.2983 m/z, C31H40O7N7 requires 622.2989 m/z;
IR (film) ν: 3344, 1668, 1554, 1516, 1201, 1136, 721 cmϪ1; [α]2D0
ϩ14.1 (c 0.5, MeOH).
N-(2-(tert-Butoxycarbonylamino)ethoxyethyl) Nꢀ-cis-p-
coumaroyl-D-arginine amide (23)
Compound 22 (78.9 mg, 0.164 mmol) was dissolved in DMF
(1.5 mL) with a trace amount of water. To this solution was
added 10 (40.4 mg, 0.246 mmol) and then 4-(4,6-dimethoxy-
1,3,5-triazin-2-yl)-4-methylmorpholinium chloride (DMTMM)
(75.2 mg, 0.272 mmol) at 0 ЊC. This solution was stirred under
an argon atmosphere. After 12 hours, additional DMTMM
O r g . B i o m o l . C h e m . , 2 0 0 3 , 1, 3 1 8 6 – 3 1 9 2
3191